Long-Term Longitudinal Analysis of Pulmonary Function before and after Biological Therapy in Severe Asthma
This study indicates that biological agents may help prevent the progressive decline in lung function in severe asthma, particularly among patients with significantly declined lung function or elevated T2 inflammation biomarkers before treatment. Further research is needed to explore differences in efficacy across various biological agents.
Authors
- Toshiaki Kikuchi
- Mayumi Sasagawa
- Toshiyuki Koya (ORCID: https://orcid.org/0000-0002-9525-3312)
- Kenjiro Shima
- Shun Naramoto (ORCID: https://orcid.org/0000-0002-3271-9613)
- Takahiro Matsuda (ORCID: https://orcid.org/0000-0002-9728-9968)
- Ami Aoki (ORCID: https://orcid.org/0000-0002-8785-5612)
- Yosuke Kimura
- Hiroshi Ueno (ORCID: https://orcid.org/0000-0002-8293-9163)
- Takashi Hasegawa
- Yui Murai
- Moe Tanaka
- Wakana Uji
Institutions
- Misasa Onsen Hospital (JP)
- Niigata University Medical and Dental Hospital (JP)
- Niigata University (JP)
Publication Details
- Journal
- International Archives of Allergy and Immunology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1159/000546394
- Citations
- 1
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.16